OBSOLETE: Hereditary thrombocytopenia-hematological cancer predisposition syndrome

Hereditary thrombocytopenia-hematological cancer predisposition syndrome is a rare inherited blood disorder that was previously recognized as a distinct condition in medical classification systems. The term 'OBSOLETE' in its name means that this syndrome has since been reclassified — its features are now understood to be part of other, more precisely defined genetic conditions. In general, this type of syndrome involves two main problems: a low platelet count (called thrombocytopenia) and an increased lifetime risk of developing blood cancers such as leukemia, myelodysplastic syndrome (MDS), or lymphoma. Platelets are tiny blood cells that help your blood clot when you are injured. When platelet counts are low, people bruise easily, bleed longer than normal from cuts, and may have frequent nosebleeds or bleeding gums. The cancer risk means that regular monitoring by a blood specialist (hematologist) is very important. Because this classification is now considered obsolete, patients who were given this diagnosis should work with their doctor to identify the specific updated genetic diagnosis that applies to them, as treatment and monitoring plans depend on the exact gene involved.

Bring these to your next appointment

• Q1.Which specific gene is responsible for my condition, and what does that mean for my cancer risk?,How often do I need blood tests and bone marrow monitoring?,Are there any activities or medications I should avoid because of my low platelet count?,Should my family members be tested for the same genetic change?,What are the early warning signs of leukemia or MDS that I should watch for?,Is bone marrow transplant an option for me, and when would it be considered?,Are there any clinical trials I should know about for my condition?

Common questions about OBSOLETE: Hereditary thrombocytopenia-hematological cancer predisposition syndrome